Frost & Sullivan has awarded ChromaDex Corp. (Irvine, CA) for its proprietary branded pTeroPure pterostilbene ingredient.
Frost & Sullivan has awarded ChromaDex Corp. (Irvine, CA) for its proprietary branded pTeroPure pterostilbene ingredient, naming it the 2010 North American Health Ingredients Most Promising Ingredient of the Year.
The award takes into account unique selling features, continued research efforts, current market acceptance and growth potential, and marketing and promotion endeavors.
Pterostilbene is a naturally occurring compound found in blueberries. It belongs to a group of compounds called phytoalexins, which are produced by plants to fight infection from bacteria or fungi. Published studies have shown that this compound may benefit those with adverse health conditions such as diabetes, high blood pressure, high cholesterol, oxidative stress, and neurodegeneration.
ChromaDex has licensed two patents pending from the USDA through the University of Mississippi. The patents focus on the ability of pterostilbene to reduce blood lipoprotein levels through PPAR-alpha activation, and pterostilbene’s effect on oxidative stress and cognitive and memory enhancement.
Other patents are also in the works, including a patent filed in collaboration with the University of California at Irvine. ChromaDex also has a processing patent from a manufacturing partner.